DNA Sequencer Price: NovaSeq, MiSeq, and NextSeq Cost Guide for Procurement

A DNA sequencer is one of the largest single line items a genomics core facility, department, or research institution will ever put on a capital equipment budget or grant justification — and manufacturers do not publish list prices. This guide is written for the person who actually has to answer “what will this cost us,” build an RFQ, or defend a purchase decision to a grants office or procurement committee: a core facility director, lab manager, or research administrator evaluating a benchtop or production-scale next-generation sequencing (NGS) platform, not someone looking for a general definition of what a sequencer does.

Why DNA Sequencer Pricing Isn’t a Single Number

Unlike a reagent or a bench instrument in the tens-of-thousands range, next-generation sequencers are sold through a direct sales/quote process, not a published price list. Illumina — the dominant platform vendor for the instruments covered in this guide — does not list purchase prices on its own site; its sequencing-platforms page directs buyers to “contact a sales representative” and separately advertises demo, rental, and leasing programs rather than posted prices. That is standard practice across the capital-equipment tier of lab instrumentation, and it has direct procurement consequences:

• Configuration changes the price. The same chassis (e.g., NextSeq 2000, NovaSeq X) is sold at different price points depending on flow cell/reagent tier, throughput ceiling, and bundled service level.
• List price and transaction price are different things. Academic, nonprofit, and government institutions routinely negotiate discounts off list, and trade-in credit for a retired instrument can materially change the net cost.
• Reported figures age quickly. Vendors periodically reprice as new chemistry generations replace old ones (as MiSeq i100 has begun to supersede the original MiSeq, and NovaSeq X has superseded NovaSeq 6000 as Illumina’s flagship production platform).

Because of this, treat any dollar figure below — including the ranges in this guide — as a starting point for budgeting and RFQ conversations, not a quotable price. Request a current, written quote from the vendor or an authorized reseller before committing a number to a grant budget or purchase order.

Reported Price Ranges by Platform

The figures below reflect publicly reported list-price ranges commonly cited in core-facility budget justifications, grant equipment-cost documentation, and industry press coverage. They are approximate, vary by region and configuration, and should be confirmed with a current vendor quote — not treated as CASRAI-verified pricing.

• MiSeq (benchtop, low-to-mid throughput) — historically the entry point into in-house NGS for a core lab, commonly reported in the roughly $100,000–$130,000 range at list price over its product lifecycle. Illumina has been transitioning customers toward the newer MiSeq i100 Series benchtop platform.
• NextSeq 1000 / NextSeq 2000 (benchtop, mid throughput) — positioned between MiSeq and NovaSeq for exome, targeted panel, and small-genome work; commonly reported in the roughly $210,000–$335,000 range depending on flow-cell/reagent tier and configuration.
• NovaSeq 6000 (production scale) — Illumina’s previous-generation high-throughput production platform, commonly reported around the $985,000–$1,000,000+ range at launch pricing; still in service at many core facilities and available in the secondary/refurbished market.
• NovaSeq X / NovaSeq X Plus (current-generation production scale) — Illumina’s current flagship high-throughput platform, commonly reported around $1.25 million at list price for the higher-throughput X Plus configuration in industry coverage since its 2023 launch.

These four tiers roughly track sequencing scale: MiSeq and the i100 Series for low-plex, quick-turnaround work; NextSeq 1000/2000 for mid-throughput exome and panel sequencing; NovaSeq 6000 and NovaSeq X/X Plus for population-scale whole-genome sequencing and high-sample-count production pipelines. Instrument price alone should not decide the purchase — see total cost of ownership below.

Total Cost of Ownership: Why the Purchase Price Is the Smaller Number

Over a typical 5-7 year instrument life, the acquisition price is often a minority of what a sequencer actually costs an institution. A procurement evaluation should model, at minimum:

• Reagent/consumables cost per run. This is usually the dominant recurring cost and scales with utilization — a heavily used production instrument can spend its full purchase price in reagents within a few years. Cost per run and cost per gigabase both matter and vary by flow-cell tier and read configuration; request per-run reagent pricing for the exact kit/configuration you intend to run, not a generic “cost per Gb” marketing figure.
• Service contract / extended warranty. Annual service contracts on production-scale sequencers commonly run a meaningful percentage of instrument list price per year once the base warranty expires; confirm what’s covered (preventive maintenance visits, parts, labor, loaner/backup instrument access) and the response-time SLA before budgeting a single annual figure.
• Facility requirements. Production-scale instruments have real power, HVAC/cooling, and floor-space specifications, and some require dedicated network/compute infrastructure for on-instrument or downstream analysis — confirm site-readiness requirements before the purchase order, not after delivery.
• Bioinformatics compute and storage. Sequencer output has to land somewhere — on-premises compute/storage, institutional HPC allocation, or cloud analysis pipelines all carry their own recurring cost that scales with the instrument’s output volume.
• Staff training and validation time. Budget for operator training and, in a regulated or accredited environment, instrument qualification/validation documentation before the instrument is generating billable or publishable data.
• Depreciation and eventual decommissioning. Capital equipment needs an end-of-life plan — data migration off the instrument, secure decommissioning, and disposal or trade-in — factored into total lifecycle cost from the start.

Building a DNA Sequencer Procurement / RFQ Process

A structured request-for-quote process, rather than a single vendor conversation, produces a defensible, comparable basis for a purchasing decision:

1. Define throughput and turnaround requirements first. Samples per run, required read length/configuration (single-end vs. paired-end, read length), and acceptable turnaround time determine which platform tier is even in scope — don’t shop NovaSeq-class throughput against MiSeq-class use cases or vice versa.
2. Request itemized, not bundled, pricing. Ask for the instrument, service contract, installation/site-prep, training, and starter reagent kit priced separately, so you can evaluate each line rather than a single bundled number.
3. Confirm service-level terms in writing. Response time, loaner-instrument availability during repair, preventive-maintenance cadence, and what triggers an out-of-warranty repair charge should all be specified in the quote or service agreement, not assumed.
4. Ask about academic/nonprofit/government pricing programs and trade-in credit. Many vendors offer institutional discount programs and instrument trade-in toward a new purchase; these can materially change net cost and are not always volunteered up front.
5. Evaluate demo, rental, and reagent-rental programs as real alternatives to purchase for institutions with variable or as-yet-unproven demand — several vendors, including Illumina, publicly advertise rental/leasing options as a lower-commitment path to in-house sequencing capacity.
6. Model total cost of ownership over the full expected instrument life, not just year one, using the categories above, before comparing vendor quotes head to head.
7. Document the evaluation. A written comparison of throughput, TCO, and service terms across quotes is what a procurement office or grants administrator will need to justify sole-source or competitive-award decisions.

New vs. Refurbished / Certified Pre-Owned Instruments

A certified pre-owned or refurbished sequencer — sold either directly by the manufacturer’s refurbished program or by an authorized reseller — can meaningfully lower the acquisition cost for a lab whose throughput needs fit an earlier-generation platform (e.g., NovaSeq 6000 rather than NovaSeq X). Before buying refurbished, confirm in writing: what warranty and service-contract eligibility transfers with the unit, whether the vendor will support the specific chemistry/reagent generation for the expected life of the instrument, and whether software/analysis pipeline support is included or has been discontinued for that model.

Buy vs. Access Through a Core Facility

Purchasing an in-house instrument is not the only path to sequencing capacity. Fee-for-service access through an institutional or commercial core facility avoids the capital outlay, service contract, and staffing overhead entirely, in exchange for per-sample or per-run service fees and shared scheduling. For labs with intermittent or unpredictable sequencing volume, modeling the cost of core-facility access against the total cost of ownership of an in-house instrument (above) is a legitimate — and often lower-risk — alternative to a purchase decision. See CASRAI’s guides on how research core facilities are organized and core facility scheduling and billing platforms for how that model works in practice, and research infrastructure funding programs if a capital purchase is the better fit and needs a funding source.

Frequently Asked Questions

How much does a DNA sequencer cost?

It depends entirely on platform tier and configuration. Benchtop instruments (MiSeq, NextSeq 1000/2000) are commonly reported in the roughly $100,000-$335,000 range; production-scale instruments (NovaSeq 6000, NovaSeq X/X Plus) are commonly reported from roughly $985,000 up to around $1.25 million. None of these figures are published list prices — Illumina sells through a direct quote process, so request a current written quote for your specific configuration before budgeting.

What is the sequencer price for a small core lab just starting NGS?

Most labs starting in-house NGS for the first time evaluate a benchtop platform (MiSeq/MiSeq i100 Series or NextSeq 1000/2000) rather than a production-scale instrument, both for lower acquisition cost and lower minimum reagent commitment per run. Whether that’s cheaper than fee-for-service core-facility access depends on expected sample volume — model both before purchasing.

What is the NovaSeq X cost?

The NovaSeq X / NovaSeq X Plus, Illumina’s current flagship production sequencer, is commonly reported around $1.25 million at list price for the higher-throughput X Plus configuration in industry coverage since its 2023 launch. This is a reported range, not a published list price, and academic/institutional pricing programs and trade-in credit can change the net figure — confirm with a current vendor quote.

What is the NovaSeq (6000) cost?

The earlier-generation NovaSeq 6000 is commonly reported in the roughly $985,000 to $1,000,000+ range at launch pricing. It remains in service at many facilities and is available on the refurbished/secondary market at a lower price point than a new instrument, subject to the refurbished-purchase considerations above.

What is the MiSeq cost?

MiSeq has commonly been reported in the roughly $100,000-$130,000 range at list price over its product lifecycle, positioning it as Illumina’s lowest-cost sequencer tier; Illumina has been transitioning new buyers toward the newer MiSeq i100 Series.

What is the NextSeq 2000 cost?

NextSeq 1000 and NextSeq 2000 are commonly reported in the roughly $210,000-$335,000 range depending on flow-cell/reagent tier and configuration, positioning the platform between MiSeq and NovaSeq for exome and targeted-panel throughput.

What is the NextSeq 1000 cost?

NextSeq 1000 is the lower-throughput sibling in the same platform family as NextSeq 2000, sharing the instrument chassis with a lower maximum output ceiling; it falls within the same commonly reported $210,000-$335,000 range depending on configuration, generally toward the lower end.

Fact-check note: dollar figures in this guide are reported ranges drawn from publicly available industry and core-facility budgeting sources, not from a published vendor price list — Illumina does not publish sequencer prices. Treat them as directional for early budgeting only, and confirm current pricing directly with the vendor or an authorized reseller before finalizing a purchase order or grant budget.